Natixis Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2M Sell
684,619
-182,154
-21% -$8.14M 0.03% 430
2026
Q1
$41.8M Sell
866,773
-2,368,138
-73% -$110M 0.06% 308
2025
Q4
$157M Buy
3,234,911
+121,530
+4% +$6.02M 0.22% 104
2025
Q3
$147M Buy
3,113,381
+327,569
+12% +$15.8M 0.21% 100
2025
Q2
$135M Sell
2,785,812
-159,173
-5% -$8.13M 0.21% 104
2025
Q1
$163M Buy
2,944,985
+34,964
+1% +$1.89M 0.3% 71
2024
Q4
$140M Buy
2,910,021
+35,828
+1% +$1.82M 0.26% 73
2024
Q3
$166M Buy
2,874,193
+114,133
+4% +$6.16M 0.32% 57
2024
Q2
$134M Buy
2,760,060
+71,713
+3% +$3.46M 0.29% 72
2024
Q1
$131M Buy
2,688,347
+222,585
+9% +$10.9M 0.3% 76
2023
Q4
$123M Sell
2,465,762
-62,527
-2% -$3.06M 0.32% 67
2023
Q3
$136M Buy
2,528,289
+346,563
+16% +$18.5M 0.41% 52
2023
Q2
$118M Buy
2,181,726
+194,439
+10% +$10.5M 0.36% 60
2023
Q1
$108M Buy
1,987,287
+299,652
+18% +$14.6M 0.37% 63
2022
Q4
$81.7M Buy
1,687,635
+813,365
+93% +$35.7M 0.31% 89
2022
Q3
$33.2M Sell
874,270
-609,009
-41% -$27.1M 0.14% 175
2022
Q2
$74.2M Buy
1,483,279
+89,054
+6% +$4.73M 0.33% 74
2022
Q1
$71.6M Buy
1,394,225
+115,329
+9% +$5.96M 0.27% 89
2021
Q4
$64.1M Buy
1,278,896
+94,632
+8% +$4.68M 0.24% 95
2021
Q3
$57.1M Sell
1,184,264
-16,008
-1% -$814K 0.23% 93
2021
Q2
$63.2M Buy
1,200,272
+57,729
+5% +$3.01M 0.3% 68
2021
Q1
$56.5M Buy
1,142,543
+109,489
+11% +$5.26M 0.29% 70
2020
Q4
$50.2M Buy
1,033,054
+27,513
+3% +$1.36M 0.29% 72
2020
Q3
$50.4M Buy
1,005,541
+17,421
+2% +$897K 0.32% 63
2020
Q2
$50.4M Sell
988,120
-17,697
-2% -$860K 0.33% 60
2020
Q1
$44M Buy
1,005,817
+105,900
+12% +$5.07M 0.36% 61
2019
Q4
$45.2M Buy
899,917
+195,127
+28% +$9.14M 0.32% 66
2019
Q3
$32.7M Buy
704,790
+127,927
+22% +$5.52M 0.26% 85
2019
Q2
$25M Buy
576,863
+124,999
+28% +$5.32M 0.2% 112
2019
Q1
$20M Buy
451,864
+151,144
+50% +$6.47M 0.18% 133
2018
Q4
$13.1M Buy
300,720
+3,776
+1% +$167K 0.13% 173
2018
Q3
$13.3M Sell
296,944
-47,421
-14% -$2.03M 0.12% 196
2018
Q2
$13.8M Buy
344,365
+27,078
+9% +$1.07M 0.13% 169
2018
Q1
$12.7M Sell
317,287
-16,380
-5% -$682K 0.13% 185
2017
Q4
$14.3M Sell
333,667
-33,400
-9% -$1.54M 0.15% 161
2017
Q3
$18.3M Sell
367,067
-15,945
-4% -$772K 0.19% 113
2017
Q2
$18.4M Sell
383,012
-95,639
-20% -$4.57M 0.2% 107
2017
Q1
$21.7M Buy
478,651
+8,456
+2% +$359K 0.24% 81
2016
Q4
$19M Sell
470,195
-35,334
-7% -$1.39M 0.23% 96
2016
Q3
$19.3M Sell
505,529
-48,471
-9% -$1.94M 0.25% 87
2016
Q2
$23.2M Buy
554,000
+48,576
+10% +$1.99M 0.32% 65
2016
Q1
$20.3M Buy
505,424
+216,956
+75% +$8.72M 0.3% 67
2015
Q4
$12.3M Sell
288,468
-19,749
-6% -$909K 0.2% 114
2015
Q3
$14.6M Buy
308,217
+6,250
+2% +$318K 0.25% 76
2015
Q2
$15M Buy
301,967
+50,610
+20% +$2.56M 0.25% 80
2015
Q1
$12.4M Buy
251,357
+21,749
+9% +$1.04M 0.22% 102
2014
Q4
$10.5M Sell
229,608
-29,050
-11% -$1.41M 0.2% 116
2014
Q3
$14.6M Sell
258,658
-54,556
-17% -$2.93M 0.29% 60
2014
Q2
$16.7M Buy
313,214
+20,347
+7% +$1.08M 0.24% 90
2014
Q1
$15.3M Buy
292,867
+10,204
+4% +$517K 0.24% 93
2013
Q4
$15.2M Buy
282,663
+26,229
+10% +$1.35M 0.25% 97
2013
Q3
$13M Buy
256,434
+905
+0.4% +$46K 0.24% 99
2013
Q2
$13.2M Buy
+255,529
New +$13.6M 0.26% 89

Other funds holding SNY

Natixis Advisors's SNY Position: Q2 2026 in Review

Natixis Advisors reduced its Sanofi (SNY) stake by 21% in Q2 2026, selling an estimated $8.14M and leaving 684,619 shares worth $29.2M. The position accounts for 0.03% of the portfolio, ranked #430.

Natixis Advisors first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $166M in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Natixis Advisors held 684,619 shares of Sanofi worth $29.2M as of Q2 2026.
  • Natixis Advisors sold 182,154 Sanofi shares in Q2 2026, an estimated $8.14M.
  • Sanofi made up 0.03% of Natixis Advisors's portfolio in Q2 2026, its #430 holding.
  • Natixis Advisors first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Sanofi position peaked at $166M in Q3 2024.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.